Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 44 min ago
Peer-reviewedCC BYInternational journal of biological sciences

LDHA Lactylation Drives Malignant Progression of Oral Squamous Cell Carcinoma via a Positive Feedback Loop with Lactate.

  1. 1Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, Guangdong 510055, China.
  2. 2Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-Sen University, Guangzhou, Guangdong 510055, China.

Abstract

Lysine lactylation (Kla) is an emerging post-translational modification closely linked to glycolysis, where it functions to regulate the activity of glycolytic enzymes. In oral squamous cell carcinoma (OSCC), elevated expression of Lactate dehydrogenase A (LDHA) drives lactate production, thereby supplying the substrate for Kla. Nevertheless, whether LDHA itself undergoes Kla in OSCC has yet to be explored. Here, we have conclusively verified that LDHA undergoes high-level Kla in OSCC tissues and cells, with its Kla abundance positively associated with intracellular lactate concentrations. Both in vitro and in vivo analyses collectively illustrated that LDHA-K318 lactylation functions as a crucial driver of OSCC malignant progression. Functionally, our investigations revealed that the LDHA-K318R mutation diminishes lactate generation and decreases global protein Kla levels. GCN5 acts as an upstream "writer" that coordinately regulates LDHA-Kla, thereby modulating lactate production and facilitating OSCC malignancy. Furthermore, we identified HDAC1 as an "eraser" that governs LDHA-Kla status. Combined administration of the GCN5 inhibitor MB-3 and the LDHA-K318 lactylation-targeting peptide (K318-pe) remarkably inhibited tumor growth in the PDX models. Our study uncovers a positive feedback loop linking lactate and glycolysis, mediated by LDHA-Kla in OSCC. This discovery implicates lactylation-associated regulators as viable therapeutic targets, opening novel perspectives for clinical application.

Related

  1. Integrative multi-omics of esophageal squamous cell carcinoma reveals immune alterations and lactylation-driven mechanisms in metastatic progression.
    Yanan Pang, Ye Gao, Guobin Liu +12
    Molecular cancerPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaEurope PMC
  2. CNIH4 as a prognostic biomarker and promoter of malignant progression in head and neck squamous cell carcinoma
    Jun Chen, Aitao Nai, Jijie Cai +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  3. Vitamin D receptor is associated with farnesyl diphosphate synthase protein stability and malignant phenotypes in esophageal squamous cell carcinoma cells
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Role of podoplanin in tongue squamous cell carcinoma and the regulation of malignant cellular behaviors via the ERK/MMP-2 signaling axis
    Xiaowei Sheng, Liping Ding, Qiang Zhang +2
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Giant cutaneous squamous cell carcinoma in situ with progression to lymph node metastasis
    Jennifer Rodriguez, Sa Rang Kim, Jeffrey R. Gehlhausen +1
    JAAD Case ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
BibTeX
@article{song2026ldha,
  title = {{LDHA Lactylation Drives Malignant Progression of Oral Squamous Cell Carcinoma via a Positive Feedback Loop with Lactate.}},
  author = {Fan Song and Chen Hou and Yingzhao Huang and Hongshi Cai and Jianfeng Liang and Yaoqi Jiang and Qiong Xu and Jinsong Hou},
  journal = {International journal of biological sciences},
  year = {2026},
  month = sep,
  doi = {10.7150/ijbs.136949},
  url = {https://europepmc.org/article/MED/42910212},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - LDHA Lactylation Drives Malignant Progression of Oral Squamous Cell Carcinoma via a Positive Feedback Loop with Lactate.
AU  - Fan Song
AU  - Chen Hou
AU  - Yingzhao Huang
AU  - Hongshi Cai
AU  - Jianfeng Liang
AU  - Yaoqi Jiang
AU  - Qiong Xu
AU  - Jinsong Hou
PY  - 2026
DA  - 2026/09/10
JO  - International journal of biological sciences
DO  - 10.7150/ijbs.136949
UR  - https://europepmc.org/article/MED/42910212
AB  - Lysine lactylation (Kla) is an emerging post-translational modification closely linked to glycolysis, where it functions to regulate the activity of glycolytic enzymes. In oral squamous cell carcinoma (OSCC), elevated expression of Lactate dehydrogenase A (LDHA) drives lactate production, thereby supplying the substrate for Kla. Nevertheless, whether LDHA itself undergoes Kla in OSCC has yet to be explored. Here, we have conclusively verified that LDHA undergoes high-level Kla in OSCC tissues and cells, with its Kla abundance positively associated with intracellular lactate concentrations. Both in vitro and in vivo analyses collectively illustrated that LDHA-K318 lactylation functions as a crucial driver of OSCC malignant progression. Functionally, our investigations revealed that the LDHA-K318R mutation diminishes lactate generation and decreases global protein Kla levels. GCN5 acts as an upstream "writer" that coordinately regulates LDHA-Kla, thereby modulating lactate production and facilitating OSCC malignancy. Furthermore, we identified HDAC1 as an "eraser" that governs LDHA-Kla status. Combined administration of the GCN5 inhibitor MB-3 and the LDHA-K318 lactylation-targeting peptide (K318-pe) remarkably inhibited tumor growth in the PDX models. Our study uncovers a positive feedback loop linking lactate and glycolysis, mediated by LDHA-Kla in OSCC. This discovery implicates lactylation-associated regulators as viable therapeutic targets, opening novel perspectives for clinical application.
SN  - 1449-2288
ER  -